Digital Pathology & AI – from Drug Development to Clinical In Vitro Diagnostics
Time: 1:45 pm
day: Day Three Track A
Details:
- How digital pathology, omics and access to quality data can pave the way for powerful and robust AI models and diagnostics
- How machine learning methodologies and approaches that combine the best of human and artificial intelligence are the key to closing the translational gap between complex biology and precision medicine – a look at the Owkin AI diagnostic portfolio
- How by partnering with others in the digital pathology ecosystem we can make our AI models more broadly accessible and support drug development in biomarker and diagnostic hotspots
